Literature DB >> 17967414

Resveratrol inhibits TNF-alpha-induced changes of adipokines in 3T3-L1 adipocytes.

Jiyun Ahn1, Hyunjung Lee, Suna Kim, Taeyoul Ha.   

Abstract

Tumor necrosis factor-alpha (TNF-alpha) is chronically elevated in adipose tissues of obese rodents and humans. Increased levels of TNF-alpha are implicated in the induction of atherogenic adipokines, such as plasminogen activator inhibitor -1 (PAI-1) and IL-6, and the inhibition of the anti-atherogenic adipokine, adiponectin. In this study, we investigated the effects of resveratrol on TNF-alpha-induced atherogenic changes of the adipokines in 3T3-L1 cells. Exposure to TNF-alpha for 24 h increased PAI-1 and IL-6 secretion and decreased adiponectin secretion. The mRNA expression of adipokines changed in parallel with mRNA expression. Resveratrol effectively reversed the secretion and mRNA expression of the atherogenic adipokines, PAI-1 and IL-6, induced by TNF-alpha. Decreased secretion levels and mRNA expression of adiponectin by TNF-alpha were also recovered by resveratrol treatment. Our results suggest that resveratrol may improve obesity-induced cardiovascular disease, particularly atherosclerosis, by attenuating the TNF-alpha-induced changes of adipokines.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17967414     DOI: 10.1016/j.bbrc.2007.10.109

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  27 in total

Review 1.  Adipokines as novel biomarkers and regulators of the metabolic syndrome.

Authors:  Yingfeng Deng; Philipp E Scherer
Journal:  Ann N Y Acad Sci       Date:  2010-11       Impact factor: 5.691

Review 2.  Mitochondrial (dys)function in adipocyte (de)differentiation and systemic metabolic alterations.

Authors:  Aurélia De Pauw; Silvia Tejerina; Martine Raes; Jaap Keijer; Thierry Arnould
Journal:  Am J Pathol       Date:  2009-08-21       Impact factor: 4.307

Review 3.  Resveratrol and diabetes.

Authors:  Natalia G Vallianou; Angelos Evangelopoulos; Christos Kazazis
Journal:  Rev Diabet Stud       Date:  2014-02-10

4.  Effect of resveratrol and orchidectomy on the vasorelaxing influence of perivascular adipose tissue.

Authors:  Charlotte Boydens; Bart Pauwels; Johan Van de Voorde
Journal:  Heart Vessels       Date:  2015-03-31       Impact factor: 2.037

Review 5.  Up- and down-regulation of adiponectin expression and multimerization: mechanisms and therapeutic implication.

Authors:  Meilian Liu; Feng Liu
Journal:  Biochimie       Date:  2012-02-10       Impact factor: 4.079

Review 6.  Novel insights of dietary polyphenols and obesity.

Authors:  Shu Wang; Naima Moustaid-Moussa; Lixia Chen; Huanbiao Mo; Anuradha Shastri; Rui Su; Priyanka Bapat; InSook Kwun; Chwan-Li Shen
Journal:  J Nutr Biochem       Date:  2014-01       Impact factor: 6.048

7.  In vitro study of the effect of diesterified alkoxyglycerols with conjugated linoleic acid on adipocyte inflammatory mediators.

Authors:  Aurelio Ocaña; Cristina Gómez-Asensio; Elena Arranz-Gutiérrez; Carlos Torres; Francisco Javier Señoráns; Guillermo Reglero
Journal:  Lipids Health Dis       Date:  2010-04-06       Impact factor: 3.876

8.  Resveratrol blunts tumor necrosis factor-alpha-induced monocyte adhesion and transmigration.

Authors:  Dong Shoo Kim; Hyang-Mi Kwon; Jung-Suk Choi; Sang-Wook Kang; Geun-Eog Ji; Young-Hee Kang
Journal:  Nutr Res Pract       Date:  2007-12-31       Impact factor: 1.926

9.  Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation.

Authors:  Stefan Bereswill; Melba Muñoz; André Fischer; Rita Plickert; Lea-Maxie Haag; Bettina Otto; Anja A Kühl; Christoph Loddenkemper; Ulf B Göbel; Markus M Heimesaat
Journal:  PLoS One       Date:  2010-12-03       Impact factor: 3.240

10.  Resveratrol protects against polychlorinated biphenyl-mediated impairment of glucose homeostasis in adipocytes.

Authors:  Nicki A Baker; Victoria English; Manjula Sunkara; Andrew J Morris; Kevin J Pearson; Lisa A Cassis
Journal:  J Nutr Biochem       Date:  2013-12       Impact factor: 6.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.